On the recordMay 3, 2021
Policies like referencing pricing and government price-settings will effectively turn our biopharma industry to a risk-averse, think-inside-the-box-rather-than-outside-the-box commodity industry.
Source
congress.govEditor's note · Context
McKinley warns that certain policies could harm innovation in the biopharma sector.
Share & report
More from David McKinley
May 24, 2021
if you don't have that kind of data, then it is pretty much impossible to estimate how long its going to take to replace all of these lead pipes.
May 25, 2021
Speaker Pelosi has said she is not going to let us go back into session until all the Members are vaccinated.
May 12, 2021
I think it is a good place for bipartisanship. That is what I am thinking, if we work together.
Other voices in this conversation
